Literature DB >> 27928012

Emergence of a Viral RNA Polymerase Variant during Gene Copy Number Amplification Promotes Rapid Evolution of Vaccinia Virus.

Kelsey R Cone1, Zev N Kronenberg1,2, Mark Yandell1,2, Nels C Elde3.   

Abstract

Viruses are under relentless selective pressure from host immune defenses. To study how poxviruses adapt to innate immune detection pathways, we performed serial vaccinia virus infections in primary human cells. Independent courses of experimental evolution with a recombinant strain lacking E3L revealed several high-frequency point mutations in conserved poxvirus genes, suggesting important roles for essential poxvirus proteins in innate immune subversion. Two distinct mutations were identified in the viral RNA polymerase gene A24R, which seem to act through different mechanisms to increase virus replication. Specifically, a Leu18Phe substitution encoded within A24R conferred fitness trade-offs, including increased activation of the antiviral factor protein kinase R (PKR). Intriguingly, this A24R variant underwent a drastic selective sweep during passaging, despite enhanced PKR activity. We showed that the sweep of this variant could be accelerated by the presence of copy number variation (CNV) at the K3L locus, which in multiple copies strongly reduced PKR activation. Therefore, adaptive cases of CNV can facilitate the accumulation of point mutations separate from the expanded locus. This study reveals how rapid bouts of gene copy number amplification during accrual of distant point mutations can potently facilitate poxvirus adaptation to host defenses. IMPORTANCE: Viruses can evolve quickly to defeat host immune functions. For poxviruses, little is known about how multiple adaptive mutations emerge in populations at the same time. In this study, we uncovered a means of vaccinia virus adaptation involving the accumulation of distinct genetic variants within a single population. We identified adaptive point mutations in the viral RNA polymerase gene A24R and, surprisingly, found that one of these mutations activates the nucleic acid sensing factor PKR. We also found that gene copy number variation (CNV) can provide dual benefits to evolving virus populations, including evidence that CNV facilitates the accumulation of a point mutation distant from the expanded locus. Our data suggest that transient CNV can accelerate the fixation of mutations conferring modest benefits, or even fitness trade-offs, and highlight how structural variation might aid poxvirus adaptation through both direct and indirect actions.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  RNA polymerase; experimental evolution; genome analysis; innate immunity; poxvirus; vaccinia virus

Mesh:

Substances:

Year:  2017        PMID: 27928012      PMCID: PMC5286894          DOI: 10.1128/JVI.01428-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Extremely high mutation rate of a hammerhead viroid.

Authors:  Selma Gago; Santiago F Elena; Ricardo Flores; Rafael Sanjuán
Journal:  Science       Date:  2009-03-06       Impact factor: 47.728

2.  A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data.

Authors:  Heng Li
Journal:  Bioinformatics       Date:  2011-09-08       Impact factor: 6.937

3.  Evolution of the mutation rate.

Authors:  Michael Lynch
Journal:  Trends Genet       Date:  2010-06-30       Impact factor: 11.639

4.  High-frequency homologous recombination in vaccinia virus DNA.

Authors:  L A Ball
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

5.  Experimental Evolution Identifies Vaccinia Virus Mutations in A24R and A35R That Antagonize the Protein Kinase R Pathway and Accompany Collapse of an Extragenic Gene Amplification.

Authors:  Greg Brennan; Jacob O Kitzman; Jay Shendure; Adam P Geballe
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

6.  Temperature-sensitive mutants in the vaccinia virus A18R gene increase double-stranded RNA synthesis as a result of aberrant viral transcription.

Authors:  C D Bayliss; R C Condit
Journal:  Virology       Date:  1993-05       Impact factor: 3.616

7.  The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2.

Authors:  M V Davies; O Elroy-Stein; R Jagus; B Moss; R J Kaufman
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

8.  A vaccinia virus isatin-beta-thiosemicarbazone resistance mutation maps in the viral gene encoding the 132-kDa subunit of RNA polymerase.

Authors:  R C Condit; R Easterly; R F Pacha; Z Fathi; R J Meis
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

9.  Wham: Identifying Structural Variants of Biological Consequence.

Authors:  Zev N Kronenberg; Edward J Osborne; Kelsey R Cone; Brett J Kennedy; Eric T Domyan; Michael D Shapiro; Nels C Elde; Mark Yandell
Journal:  PLoS Comput Biol       Date:  2015-12-01       Impact factor: 4.475

10.  Adaptive gene amplification as an intermediate step in the expansion of virus host range.

Authors:  Greg Brennan; Jacob O Kitzman; Stefan Rothenburg; Jay Shendure; Adam P Geballe
Journal:  PLoS Pathog       Date:  2014-03-13       Impact factor: 6.823

View more
  15 in total

1.  Inactivation of Genes by Frameshift Mutations Provides Rapid Adaptation of an Attenuated Vaccinia Virus.

Authors:  Tatiana G Senkevich; Erik K Zhivkoplias; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

2.  Proteomic and genomic signatures of repeat instability in cancer and adjacent normal tissues.

Authors:  Erez Persi; Davide Prandi; Yuri I Wolf; Yair Pozniak; Georgina D Barnabas; Keren Levanon; Iris Barshack; Christopher Barbieri; Paola Gasperini; Himisha Beltran; Bishoy M Faltas; Mark A Rubin; Tamar Geiger; Eugene V Koonin; Francesca Demichelis; David Horn
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-06       Impact factor: 11.205

3.  RNA Polymerase Mutations Selected during Experimental Evolution Enhance Replication of a Hybrid Vaccinia Virus with an Intermediate Transcription Factor Subunit Replaced by the Myxoma Virus Ortholog.

Authors:  Carey A Stuart; Erik K Zhivkoplias; Tatiana G Senkevich; Linda S Wyatt; Bernard Moss
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

4.  Combined Proteomics/Genomics Approach Reveals Proteomic Changes of Mature Virions as a Novel Poxvirus Adaptation Mechanism.

Authors:  Marica Grossegesse; Joerg Doellinger; Alona Tyshaieva; Lars Schaade; Andreas Nitsche
Journal:  Viruses       Date:  2017-11-10       Impact factor: 5.048

5.  Modeling multipartite virus evolution: the genome formula facilitates rapid adaptation to heterogeneous environments.

Authors:  Mark P Zwart; Santiago F Elena
Journal:  Virus Evol       Date:  2020-05-08

6.  A copy number variant is associated with a spectrum of pigmentation patterns in the rock pigeon (Columba livia).

Authors:  Rebecca Bruders; Hannah Van Hollebeke; Edward J Osborne; Zev Kronenberg; Emily Maclary; Mark Yandell; Michael D Shapiro
Journal:  PLoS Genet       Date:  2020-05-20       Impact factor: 5.917

7.  Expandable and reversible copy number amplification drives rapid adaptation to antifungal drugs.

Authors:  Robert T Todd; Anna Selmecki
Journal:  Elife       Date:  2020-07-20       Impact factor: 8.140

8.  Long read sequencing reveals poxvirus evolution through rapid homogenization of gene arrays.

Authors:  Thomas A Sasani; Kelsey R Cone; Aaron R Quinlan; Nels C Elde
Journal:  Elife       Date:  2018-08-29       Impact factor: 8.140

Review 9.  Adaptation by copy number variation in monopartite viruses.

Authors:  Avraham Bayer; Greg Brennan; Adam P Geballe
Journal:  Curr Opin Virol       Date:  2018-07-14       Impact factor: 7.090

10.  In vitro evolution of herpes simplex virus 1 (HSV-1) reveals selection for syncytia and other minor variants in cell culture.

Authors:  Chad V Kuny; Christopher D Bowen; Daniel W Renner; Christine M Johnston; Moriah L Szpara
Journal:  Virus Evol       Date:  2020-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.